Biotech

All Articles

8 months after a $213M fundraise, genetics publisher Tome makes reduces

.After bring up $213 million in 2023-- one of the year's largest private biotech shots-- Volume Bios...

BioMarin builds exec group with biotech vets-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant leadership hirings, firings and a...

Biopharma Q2 VC struck highest level considering that '22, while M&ampA reduced

.Venture capital financing into biopharma rose to $9.2 billion throughout 215 deals in the second qu...

Bicara, Zenas seek IPOs to push late-phase resources toward market

.Bicara Rehabs and Zenas Biopharma have offered clean motivation to the IPO market along with filing...

Genentech to shut cancer cells immunology research study department

.Genentech will shut its cancer cells immunology study division, and also unit mind as well as well-...

Kezar falls sound lump but to verify its worth in period 1 trial

.Kezar Life Sciences is actually falling its unpromising period 1 strong tumor medicine as the biote...

Acelyrin loses izokibep, lays off 3rd of workers

.In spite of izokibep maintaining its own newly found winning streak in the medical clinic, Acelyrin...

Rivus' phase 2 obesity-related heart failure test attacks endpoint

.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing medicine pros...

Ovid halts preclinical job, IV plan after soticlestat stop working

.Ovid Rehab actually showed final month that it was trimming back its own headcount as the firm brow...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has opened up a $700 thousand R&ampD facility in the Boston Port, improving its RNA as we...